Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.27USD
8.05 MUSD
100.89 MUSD
26.13 M
About RAYSEARCH LABORATORIES AB SER. B
Sector
Industry
CEO
Johan Löf
Website
Headquarters
Stockholm
Employees (FY)
389
Founded
1988
ISIN
SE0000135485
FIGI
BBG00262DM83
RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research. RayStation is the company's proprietary treatment planning system. Partner Products include proton and intensity modulated radiation therapy, automatic treatment planning, quality assurance, and radiobiology. Research offers long term study of new methods and techniques in radiation treatment. The company was founded by Johan Löf, Erik Hedlund, Carl Filip Bergendal, Anders Brahme, Bengt Lind, and Anders Liander in 2000 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RSLBF is 13.23 USD — it has decreased by 1.42% in the past 24 hours. Watch Raysearch Laboratories AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Raysearch Laboratories AB stocks are traded under the ticker RSLBF.
RSLBF stock has risen by 58.82% compared to the previous week, the month change is a 58.82% rise, over the last year Raysearch Laboratories AB has showed a 81.48% increase.
We've gathered analysts' opinions on Raysearch Laboratories AB future price: according to them, RSLBF price has a max estimate of 12.54 USD and a min estimate of 12.54 USD. Watch RSLBF chart and read a more detailed Raysearch Laboratories AB stock forecast: see what analysts think of Raysearch Laboratories AB and suggest that you do with its stocks.
RSLBF reached its all-time high on Jun 27, 2017 with the price of 28.00 USD, and its all-time low was 2.20 USD and was reached on Dec 27, 2011. View more price dynamics on RSLBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RSLBF stock is 1.44% volatile and has beta coefficient of 0.93. Track Raysearch Laboratories AB stock price on the chart and check out the list of the most volatile stocks — is Raysearch Laboratories AB there?
Today Raysearch Laboratories AB has the market capitalization of 464.49 M, it has increased by 3.96% over the last week.
Yes, you can track Raysearch Laboratories AB financials in yearly and quarterly reports right on TradingView.
Raysearch Laboratories AB is going to release the next earnings report on Aug 16, 2024. Keep track of upcoming events with our Earnings Calendar.
RSLBF earnings for the last quarter are 0.10 USD per share, whereas the estimation was 0.07 USD resulting in a 40.79% surprise. The estimated earnings for the next quarter are 0.08 USD per share. See more details about Raysearch Laboratories AB earnings.
Raysearch Laboratories AB revenue for the last quarter amounts to 24.02 M USD despite the estimated figure of 24.75 M USD. In the next quarter revenue is expected to reach 25.52 M USD.
RSLBF net income for the last quarter is 3.43 M USD, while the quarter before that showed 3.11 M USD of net income which accounts for 10.11% change. Track more Raysearch Laboratories AB financial stats to get the full picture.
Yes, RSLBF dividends are paid annually. The last dividend per share was 0.19 USD. As of today, Dividend Yield (TTM)% is 0%. Tracking Raysearch Laboratories AB dividends might help you take more informed decisions.
Raysearch Laboratories AB dividend yield was 0.78% in 2023, and payout ratio reached 29.42%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 23, 2024, the company has 389.00 employees. See our rating of the largest employees — is Raysearch Laboratories AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Raysearch Laboratories AB EBITDA is 35.48 M USD, and current EBITDA margin is 39.76%. See more stats in Raysearch Laboratories AB financial statements.
Like other stocks, RSLBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Raysearch Laboratories AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Raysearch Laboratories AB technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Raysearch Laboratories AB stock shows the strong buy signal. See more of Raysearch Laboratories AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.